Close

Keryx Biopharma (KERX) Receives U.S. Patent Covering Hyperphosphatemia Treatment Method

October 1, 2014 7:34 AM EDT Send to a Friend
Keryx Biopharma (Nasdaq: KERX) announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 8,846,976. The patent ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login